CDH3 and breast carcinoma: Our results are discordant with the majority of available studies in human breast cancer, which found P-cadherin significantly associated with several aggressive characteristics, such as high histological grade and proliferation, as well as with a poor prognosis [60, 68, 74–78], which has raised the interest on P-cadherin as a potential prognostic marker for this disease.